Expected timeline: Appetite suppression from tirzepatide begins within the first two weeks
Researchers believe that dual action is one reason it often leads to greater weight loss than medications that target only GLP-1
Ozempic is the 4 th once-weekly glucagon like peptide-1 receptor agonist (GLP-1 RA) medication to enter the market after Bydureon (exenatide extended release), Trulicity (dulaglutide), and Tanzeum (albiglutide)
(24:32) Section 5.2 Marketing Your Weight Loss Clinic (13:32) Section 5.3 Informed Consents, Documentation Essentials, Medications, Labs, Pricing, and Practice Maintenance (55:38) Course Post-Test Course Evaluation Downloadable Audio Lectures Practice Forms: Informed Consent, Patient Intake Form, Privacy Policies, Clinic Policies, and Indemnification Clause Additional Resources: Medication and Treatment Protocols, 34-Page Course Workbook, Semaglutide/Tirzepatide Cheat Sheet, Questionnaires, etc